undamentalytics Newsletter
Sign in

Agenus Inc balance sheet

At the end of fiscal 2025, Agenus Inc had total assets of $227m and shareholders' equity of −$271m. It held $3.0m in cash against $45.5m of debt: net debt of $42.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents202011212726137716053621002921797640319
Receivables—0010010111116123260215
Inventory—0000000000———————
Total current assets—2112232843184917475871143322131124613379
Goodwill—333318232223232325252525242424
Total assets—3120293575242157138136155215466414314226227173
Accounts payable—11112458141417304161618359
Deferred revenue (current)—22220434229171212000—
Total current liabilities—55510929415668122130157189256221323232
Short-term debt—00041002101111034530
Long-term debt—34333610511413114213131913131330030
Total debt003839106114131163141420141413354630
Shareholders' equity−17−15−21−18−42371−39−76−172−225−20434−61−160−326−271−199
Net debt (negative = net cash)−20−202718−18−19−2259103−39−48−80−278−165−63−54312
Shares outstanding——————————————20m24m35m43m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: AGEN vs MESOAGEN vs KPTIAGEN vs RCUSAGEN vs BEAM

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Agenus Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agenus Inc.